DNA

#3010
Ginkgo Bioworks Holdings, Inc.
7.7250 USD
+16.34%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
7.5600
7.7400
Year Range
5.3700
9.7200
Daily Change
+16.34%
Monthly Change
+10.36%
6 month change
-13.01%
Year Change
-13.01%
Previous Close
6.6400
Open
7.5600
Bid
Ask
Low
7.5600
High
7.7400
Volume
495
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
Value 20212022202320242025 TTM
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios
Per share metrics

Ginkgo Bioworks Holdings Inc Class A

Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.

News